Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells

Biochem Biophys Res Commun. 2014 Jul 18;450(1):360-5. doi: 10.1016/j.bbrc.2014.05.109. Epub 2014 Jun 2.

Abstract

Bone remodeling is a continuous process regulated by several hormones such as estrogens and parathyroid hormone (PTH). Here we investigated the influence of PTH on estrogen receptor alpha (ERα)-dependent transcriptional activity in MC3T3-E1 osteoblasts. Cells that were transfected with an ER-responsive reporter plasmid and treated with PTH showed increased luciferase activity. However, in the presence of 17β-estradiol, we observed that PTH inhibited ERα-mediated transcription. cAMP mimicked the effects by PTH, and the findings were confirmed in COS-1 cells transfected with expression vector encoding the catalytic subunit of cAMP-dependent protein kinase (PKA). Furthermore, PTH exhibited specific effects on the mRNA expression of the decoy receptor osteoprotegerin (OPG) and the receptor activator of NF kappa-B ligand (RANKL) in MC3T3-E1 osteoblasts. In the absence of 17β-estradiol, PTH and cAMP enhanced the OPG/RANKL ratio, whereas, OPG/RANKL was suppressed when estradiol was present. In conclusion, our results indicate that the presence of estradiol determines whether PTH and cAMP stimulates or inhibits ERα-dependent activity and the OPG/RANKL mRNA expression in an osteoblastic cell line.

Keywords: Estradiol; Estrogen receptor; MC3T3 cells; Osteoblast; PTH; cAMP.

MeSH terms

  • 3T3 Cells
  • Animals
  • COS Cells
  • Cell Differentiation / drug effects
  • Cell Differentiation / physiology
  • Chlorocebus aethiops
  • Estradiol / pharmacology*
  • Estrogen Receptor alpha / metabolism*
  • Mice
  • Osteoblasts / cytology*
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Parathyroid Hormone / administration & dosage*
  • Transcriptional Activation / drug effects
  • Transcriptional Activation / physiology*

Substances

  • Estrogen Receptor alpha
  • Parathyroid Hormone
  • Estradiol